This mRNA vaccine production facility, built from recycled shipping containers, should eventually employ around 100 people, on a 35,000 square meter site. This is Africa’s second mRNA vaccine plant, following an initial partnership in South Africa between biotech companies Afrigen and Biovac, supported by the WHO and the South African Medical Research Council.
Continuing its ambitious policy in the field, Djibouti is part of an increasingly qualitative African medical offering, striving to understand the challenges facing the health economy. Despite its small population, the Republic aspires to be one of the health leaders in the Horn of Africa, by becoming a pool of excellence and reference in the medical field.
While the African continent has long been plagued by the HIV epidemic, many countries have since embarked on ambitious health policies, barely slowed by the Covid episode. On this December 1st, World AIDS Day provides an opportunity to take stock of the situation, and to highlight issues that go far beyond the health and medical impact of the epidemic, to include new economic and socio-cultural implications.